Monoclonal Antibody Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2
Clinical trial NCT00019812 · COMPLETED
Trial details
- NCT number
- NCT00019812
- Sponsor
- National Institutes of Health Clinical Center (CC)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-08-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.